http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400068-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c1a7e80a5f8076d11cdd924071972e0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
filingDate 2021-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_582c674ddd3ba812258af959b2155db7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1735e0134dbc88c4dcc415d8e4b90529
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe9dd1c29526a47e9c009891890c40e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_646297ef97e31d71bada6595579b1f07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72468afa6996e6f92f008cc519d2e8da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b403604452605ff4d95d70b24b69ec5
publicationDate 2022-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-11400068-B2
titleOfInvention Liquid ready-to-use formulation of levothyroxine
abstract The present invention relates to liquid formulations of levothyroxine or a pharmaceutically acceptable salt thereof intended for parenteral administration, wherein the formulations are devoid of tromethamine. In particular, the invention provides a stable ready-to-use liquid formulation of levothyroxine or a pharmaceutically acceptable salt thereof intended for parenteral administration, wherein the formulation is devoid of tromethamine. The formulations prepared by using the current invention exhibit good physical and chemical stability.
priorityDate 2020-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018214374-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23690433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454072122

Total number of triples: 25.